InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,518.00
(
0.53%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
71.23
(
-2.68%
)
Bitcoin
63,720.39
(
0.93%
)
Post# of 253225
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: DewDiligence post# 163767

Wednesday, 07/10/2013 10:03:39 AM

Wednesday, July 10, 2013 10:03:39 AM

Post# of 253225
I've never implicitly handicapped the three trials. I merely pointed out that, of the 3 trials, Eyeguard B is the only one with Ph2 results which introduces an additional risk factor to the investment decision. For the record, I agree with your and iwfal's assessment.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up